These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 20157412)

  • 1. Differential expression of stem cell markers and vascular endothelial growth factor in human retinoblastoma tissue.
    Kim M; Kim JH; Kim JH; Kim DH; Yu YS
    Korean J Ophthalmol; 2010 Feb; 24(1):35-9. PubMed ID: 20157412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stem cell markers: ABCG2 and MCM2 expression in retinoblastoma.
    Mohan A; Kandalam M; Ramkumar HL; Gopal L; Krishnakumar S
    Br J Ophthalmol; 2006 Jul; 90(7):889-93. PubMed ID: 16556617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Angiogenic Factors in Invasive Retinoblastoma Tumors Is Associated With Increase in Tumor Cells Expressing Stem Cell Marker Sox2.
    Garcia JR; Gombos DS; Prospero CM; Ganapathy A; Penland RL; Chévez-Barrios P
    Arch Pathol Lab Med; 2015 Dec; 139(12):1531-8. PubMed ID: 26619025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cancer stem cell characteristics in retinoblastoma.
    Seigel GM; Campbell LM; Narayan M; Gonzalez-Fernandez F
    Mol Vis; 2005 Sep; 11():729-37. PubMed ID: 16179903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of vascular endothelial growth factor (VEGF) and its receptors is regulated in eyes with intra-ocular tumours.
    Stitt AW; Simpson DA; Boocock C; Gardiner TA; Murphy GM; Archer DB
    J Pathol; 1998 Nov; 186(3):306-12. PubMed ID: 10211121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic characterization of retinoblastoma for the presence of putative cancer stem-like cell markers by flow cytometry.
    Balla MM; Vemuganti GK; Kannabiran C; Honavar SG; Murthy R
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1506-14. PubMed ID: 19029022
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Irresponsiveness of two retinoblastoma cases to conservative therapy correlates with up- regulation of hERG1 channels and of the VEGF-A pathway.
    Fortunato P; Pillozzi S; Tamburini A; Pollazzi L; Franchi A; La Torre A; Arcangeli A
    BMC Cancer; 2010 Sep; 10():504. PubMed ID: 20860824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human embryonic and neuronal stem cell markers in retinoblastoma.
    Seigel GM; Hackam AS; Ganguly A; Mandell LM; Gonzalez-Fernandez F
    Mol Vis; 2007 Jun; 13():823-32. PubMed ID: 17615543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCG2: a potential marker of stem cells and novel target in stem cell and cancer therapy.
    Ding XW; Wu JH; Jiang CP
    Life Sci; 2010 Apr; 86(17-18):631-7. PubMed ID: 20159023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hypoxia-induced lncRNA ANRIL promotes cisplatin resistance in retinoblastoma cells through regulating ABCG2 expression.
    Yin X; Liao Y; Xiong W; Zhang Y; Zhou Y; Yang Y
    Clin Exp Pharmacol Physiol; 2020 Jun; 47(6):1049-1057. PubMed ID: 32173903
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [In vitro study on expression of tumor stem cell biomarker and transdifferentiation towards endothelial cells of retinoblastoma cells under hypoxia condition].
    Zhang LN; Zhao GQ; Wang Q; Niu YJ; Xu Q; Yang WY
    Zhonghua Yan Ke Za Zhi; 2013 Aug; 49(8):736-43. PubMed ID: 24246814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phosphorylation of p27(KIP1) in the developing retina and retinoblastoma.
    Kase S; Yoshida K; Nakayama KI; Nakayama K; Ikeda H; Harada T; Harada C; Ohgami K; Shiratori K; Ohno S
    Int J Mol Med; 2005 Aug; 16(2):257-62. PubMed ID: 16012758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hypoxia-induced expression of vascular endothelial growth factor by retinal cells is a common factor in neovascularizing ocular diseases.
    Pe'er J; Shweiki D; Itin A; Hemo I; Gnessin H; Keshet E
    Lab Invest; 1995 Jun; 72(6):638-45. PubMed ID: 7540233
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic features of retinoblastoma and expression of VEGF and Ki-67 after comprehensive treatment].
    Xue K; Qian J; Bi YW; Yao YQ; Yuan YF; DA CD
    Zhonghua Yan Ke Za Zhi; 2011 Feb; 47(2):134-41. PubMed ID: 21426843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Leucine-Rich α-2-Glycoprotein-1 (LRG-1) Expression in Retinoblastoma.
    Amer R; Tiosano L; Pe'er J
    Invest Ophthalmol Vis Sci; 2018 Feb; 59(2):685-692. PubMed ID: 29392314
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Parvalbumin, a horizontal cell-associated calcium-binding protein in retinoblastoma eyes.
    Kivelä T
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1044-8. PubMed ID: 9579485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cancer Stem Cells with Overexpression of Neuronal Markers Enhance Chemoresistance and Invasion in Retinoblastoma.
    Balaji S; Santhi R; Kim U; Muthukkaruppan V; Priya CG; Vanniarajan A
    Curr Cancer Drug Targets; 2020; 20(9):710-719. PubMed ID: 32364077
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [HIF-1alpha, HPSE and VEGF promote malignant progression of retinoblastoma].
    Wang XL; Niu YJ; Ma JM
    Zhonghua Yan Ke Za Zhi; 2010 Feb; 46(2):140-4. PubMed ID: 20388348
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of vascular endothelial growth factor (VEGF) in retinoblastoma but not in posterior uveal melanoma.
    Kvanta A; Steen B; Seregard S
    Exp Eye Res; 1996 Nov; 63(5):511-8. PubMed ID: 8994354
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential CRX and OTX2 expression in human retina and retinoblastoma.
    Glubrecht DD; Kim JH; Russell L; Bamforth JS; Godbout R
    J Neurochem; 2009 Oct; 111(1):250-63. PubMed ID: 19686387
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.